Latham & Watkins Advises Warburg Pincus in Everise Investment

Warburg Pincus, a leading global growth investor, and Everise, a leading global healthcare services outsourcing company, have announced that Warburg Pincus has agreed to invest in Everise. Warburg Pincus joins existing investor Brookfield and both investors are committed to accelerating the growth trajectory of Everise through business expansion and M&A. Warburg Pincus’ investment values Everise at around US$1 billion.

A multi-jurisdictional Latham & Watkins LLP team represented Warburg Pincus in the transaction. The corporate deal team was jointly led by partners Amy Beckingham, Alex Kelly, and Shaun Hartley, with associates Julian Azran, Sophia Yang, Elisabeth Su-Li Ong, and Alizah Charaniya. Advice was also provided on benefits and executive compensation matters by partner Adam Kestenbaum and counsel Krisa Benskin, with associates Daniel Gocek and Kevin Matheny; on healthcare regulatory matters by partner Jason Caron and counsel Nicole Liffrig Molife, with associates Margaret Rote and Leia Gu; on tax matters by partner Matthew Dewitz, with associate Shruti Hazra; on regulatory compliance matters by partner Kaede Toh, with associate Evangeline Tsui; on labor and employment matters by partner Nineveh Alkhas, with associate Laura Waller; on data privacy matters by partner Marissa Boynton and counsels Danielle van der Merwe and Esther Franks, with associates Kathryn Parsons-Reponte and Victoria Wan; on insurance regulatory matters by counsel Alexander Traum; on antitrust matters by partners Jason Cruise and Max Hauser and counsel Philipp Studt, with associates Helena Hofmann and Ivy Ziedrich; and on intellectual property matters by partner Morgan Brubaker, with associate Lyle Stewart.